Literature DB >> 8873051

Accuracy of case-reported family history of melanoma in Queensland, Australia.

J F Aitken1, P Youl, A Green, R MacLennan, N G Martin.   

Abstract

A positive family history is used in clinical practice as an indication of increased melanoma risk, yet there are no data on the accuracy of reported family histories of melanoma. The validity of case-reported family history of melanoma was assessed in the course of a family and twin study of melanoma in Queensland, Australia, conducted among the families of 2,118 melanoma cases diagnosed in Queensland between 1982 and 1990. A total of 913 melanoma cases made 1,267 reports of melanoma among their first-degree relatives. A total of 1,040 of these reports were checked, first through relatives themselves and then, if the relative also said they had had melanoma, through the relative's medical records. Medical confirmation of melanoma as the diagnosis was obtained for 623 reports (59.9%; 95% confidence interval 56.9-62.9): a false-positive reporting rate by cases of 40.1%. The level of false-positive reporting was lower for cases under 70 years of age, for women, for cases whose own diagnosis of melanoma was more than 5 years earlier, and for cases with three or more relatives with melanoma. Media campaigns in Queensland aimed at increasing skin cancer awareness, and confusion between melanoma and other more common actinic neoplasma (basal and squamous cell carcinomas), may partly explain the high false-positive reporting rate observed here. For this reason, It is difficult to generalize these findings to northern hemisphere populations where skin cancer is not such an important public health issue.

Entities:  

Mesh:

Year:  1996        PMID: 8873051     DOI: 10.1097/00008390-199608000-00006

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  10 in total

1.  Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families.

Authors:  Jazlyn Read; Judith Symmons; Jane M Palmer; Grant W Montgomery; Nicholas G Martin; Nicholas K Hayward
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

2.  High accuracy of family history of melanoma in Danish melanoma cases.

Authors:  Karin A W Wadt; Krzysztof T Drzewiecki; Anne-Marie Gerdes
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

Review 3.  Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.

Authors:  K Hemminki; C Eng
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

4.  Exposure to mass media health information, skin cancer beliefs, and sun protection behaviors in a United States probability sample.

Authors:  Jennifer Hay; Elliot J Coups; Jennifer Ford; Marco DiBonaventura
Journal:  J Am Acad Dermatol       Date:  2009-07-10       Impact factor: 11.527

5.  Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines.

Authors:  K Vuong; B K Armstrong; M Drummond; J L Hopper; J H Barrett; J R Davies; D T Bishop; J Newton-Bishop; J F Aitken; G G Giles; H Schmid; M A Jenkins; G J Mann; K McGeechan; A E Cust
Journal:  Br J Dermatol       Date:  2019-09-22       Impact factor: 9.302

6.  Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study.

Authors:  Anne E Cust; Helen Schmid; Judith A Maskiell; Jodie Jetann; Megan Ferguson; Elizabeth A Holland; Chantelle Agha-Hamilton; Mark A Jenkins; John Kelly; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Graham J Mann
Journal:  Am J Epidemiol       Date:  2009-11-03       Impact factor: 4.897

7.  Familial risk of urological cancers: data for clinical counseling.

Authors:  Kari Hemminki; Xinjun Li; Kamila Czene
Journal:  World J Urol       Date:  2003-11-13       Impact factor: 4.226

8.  Risk of breast cancer not increased in translocation 11;22 carriers: analysis of 80 pedigrees.

Authors:  Melissa T Carter; Nicholas J Barrowman; Stephanie A St Pierre; Beverly S Emanuel; Kym M Boycott
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

9.  Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition.

Authors:  Karin A W Wadt; Lauren G Aoude; Lotte Krogh; Lone Sunde; Anders Bojesen; Karen Grønskov; Nine Wartacz; Jakob Ek; Morten Tolstrup-Andersen; Mette Klarskov-Andersen; Åke Borg; Steffen Heegaard; Jens F Kiilgaard; Thomas V O Hansen; Kerenaftali Klein; Göran Jönsson; Krzysztof T Drzewiecki; Morten Dunø; Nicholas K Hayward; Anne-Marie Gerdes
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

10.  Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK.

Authors:  Anne E Cust; Mark Harland; Enes Makalic; Daniel Schmidt; James G Dowty; Joanne F Aitken; Chantelle Agha-Hamilton; Bruce K Armstrong; Jenny H Barrett; May Chan; Yu-Mei Chang; Joanne Gascoyne; Graham G Giles; Elizabeth A Holland; Richard F Kefford; Kairen Kukalizch; Johanna Lowery; Juliette A Randerson-Moor; Helen Schmid; Claire F Taylor; Linda Whitaker; John L Hopper; Julia A Newton-Bishop; Graham J Mann; D Timothy Bishop; Mark A Jenkins
Journal:  J Med Genet       Date:  2011-02-15       Impact factor: 6.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.